Global Prevalence of Nosocomial Multidrug-Resistant Klebsiella pneumoniae : A Systematic Review and Meta-Analysis

Global Prevalence of Nosocomial Multidrug-Resistant Klebsiella pneumoniae : A Systematic Review and Meta-Analysis

The emergence of nosocomial multidrug-resistant is an escalating public health threat worldwide. The prevalence of nosocomial infections due to was recorded up to 10%. In this systematic review and meta-analysis, which were conducted according to the guidelines of Preferred Reporting Items for Syste...

Full description

Saved in:
Bibliographic Details
Published in:Antibiotics (Basel) Vol. 10; no. 12; p. 1508
Main Authors: Mohd Asri, Nur Ain, Ahmad, Suhana, Mohamud, Rohimah, Mohd Hanafi, Nurmardhiah, Mohd Zaidi, Nur Fatihah, Irekeola, Ahmad Adebayo, Shueb, Rafidah Hanim, Yee, Leow Chiuan, Mohd Noor, Norhayati, Mustafa, Fatin Hamimi, Yean, Chan Yean, Yusof, Nik Yusnoraini
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 08-12-2021
MDPI
Subjects:
antibiotic resistance
Antibiotics
Bias
Drug resistance
Health care
Health risks
Heterogeneity
Hospitalization
Hospitals
Klebsiella
Klebsiella pneumoniae
Meta-analysis
Multidrug resistance
multidrug-resistant
nosocomial
Nosocomial infection
Nosocomial infections
Pathogens
prevalence
Public health
Reviews
Systematic Review
worldwide
North America
prevalence
nosocomial
antibiotic resistance
meta-analysis
worldwide
systematic review
Klebsiella pneumoniae
multidrug-resistant
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The emergence of nosocomial multidrug-resistant is an escalating public health threat worldwide. The prevalence of nosocomial infections due to was recorded up to 10%. In this systematic review and meta-analysis, which were conducted according to the guidelines of Preferred Reporting Items for Systematic Review and Meta-Analysis, 1092 articles were screened from four databases of which 47 studies fulfilled the selected criteria. By performing a random-effect model, the pooled prevalence of nosocomial multidrug-resistant was estimated at 32.8% (95% CI, 23.6-43.6), with high heterogeneity (I 98.29%, -value < 0.001). The estimated prevalence of this pathogen and a few related studies were discussed, raising awareness of the spread of multidrug-resistant in the healthcare setting. The emergence of nosocomial multidrug-resistant is expected to increase globally in the future, and the best treatments for treating and preventing this pathogen should be acknowledged by healthcare staff.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2079-6382
2079-6382
DOI:10.3390/antibiotics10121508